| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8223400 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
Several treatment-related risk factors predict the development of symptomatic pneumonitis, and elderly patients who undergo CCRT with carboplatin-paclitaxel chemotherapy are at highest risk. Fatal pneumonitis, although uncommon, is related to dosimetric factors and tumor location.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
David A. MD, MSc, PhD, Suresh MRCP, FRCR, PhD, Kayoko MD, Robert B. MD, Ramesh MD, PhD, Marta MD, Jeffrey D. MD, Tae Hyun MD, Sara MD, Lawrence B. MD, Luigi MD, PhD, Larry MSc, George MD, MSc,